The U.S. has opened a manufacturing facility in Dallas, N.C., to increase domestic production of pipette tip materials, which are widely used in diagnostics and life sciences.
The new facility will produce 1,210 tons of Carbon Black each month — a medical-grade compound found in pipette tips, which are used in disease testing, blood sample analysis and drug development, according to a June 10 news release from the Administration for Strategic Preparedness and Response, a division of HHS.
ASPR previously awarded $80 million to Premix Oy, a manufacturer, to support the opening of the facility. The move aligns with President Trump’s broader efforts to incentivize domestic manufacturing of drugs and medical supplies.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.